Skip to main content
UKHSA data dashboard

BetaThis is a new service - your feedback will help us to improve it.

Information
Changes to dashboard update frequency over the festive period

Some of the metrics will be updated on Wednesday 24 December at 2pm. The dashboard will not be updated the following week commencing Monday 29 December. Normal updates will resume for all metrics in the new year on Thursday 8 January at 4pm. More info.

BackEntry title:

Hepatitis C percentage of people injecting drugs dependent on opioids who have received opioid agonist therapy

Last updated on Thursday, 10 April 2025 at 03:30pm

Summary

Topic
Hepatitis-C
Category
headline
API name
hepatitis-c_headline_PWIDUOpoidsROAT

Rationale

Measures to prevent transmission of hepatitis C virus are a cornerstone of the public health response to eliminate hepatitis C as a public health threat in England. Harm reduction interventions such as opioid agonist therapy (OAT) are important for people who inject drugs in order to prevent and reduce the risk of transmission of hepatitis C virus as well as reduce the risk of reinfection following treatment.

Definition

This metric shows the proportion of people who inject drugs who are dependent on opioids that have received OAT.

Methodology

This figure was calculated by comparing the most recent opiate use prevalence estimates from the Department of Health and Social Care (DHSC) and the UKHSA with prescribing data from DHSC’s National Drug Treatment Monitoring System.

Back to top